MedPath
TGA Approval

RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler (396689)

396689

RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler

AstraZeneca Pty Ltd

December 6, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a69854faa61e770ba487718c72419eb9.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3f953228b2df05d7b866fe49615dcc1a.pdf

Active Ingredients

budesonide

formoterol fumarate dihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler (396689) - TGA 批准文号 | MedPath